Antitumour activity of some plants from Meghalaya and Mizoram against murine ascites Dalton's lymphoma

Indian Journal of Experimental Biology

Volumn 42, Issue 10, 2004, Pages 981-988

  Rosangkima, G ^a   Prasad, S B ^a  

^a NORTH EASTERN HILL UNIVERSITY   (India)

Author keywords

Antitumour activity; Dalton's lymphoma; Dillenia pentagyna; Glutathione

Indexed keywords

CONCENTRATION (PROCESS); GROWTH KINETICS; METHANOL; TUMORS;

ANTITUMOR ACTIVITY; DALTON'S LYMPHOMA; LYMPHOMA;

PROTEINS;

ANTINEOPLASTIC AGENT; GLUTATHIONE; PLANT EXTRACT;

AGERATUM; ANIMAL; ARTICLE; DILLENIACEAE; INDIA; ISOLATION AND PURIFICATION; LYMPHOMA; MEDICINAL PLANT; METABOLISM; MOUSE; PHYTOTHERAPY; POTENTILLA; TAXUS;

AGERATUM; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DILLENIACEAE; GLUTATHIONE; INDIA; LYMPHOMA; MICE; PHYTOTHERAPY; PLANT EXTRACTS; PLANTS, MEDICINAL; POTENTILLA; TAXUS;

AGERATUM CONYZOIDES; BLUMEA; DILLENIA; LANCEOLARIA; MURINAE; POTENTILLA; TAXUS BACCATA;

EID: 5344254002     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Black D J & Livingston R B, Antineoplastic drugs in 1990: A review (Part I), Drugs, 39 (1990) 489.
2. Black D J & Livingston R B, Antineoplastic drugs in 1990: A review (Part II), Drugs, 39 (1990) 652.
3. Kartalou M & Essigmann J M, Mechanisms of resistance to cisplatin, Mutation Res, 478 (2001) 23.
4. Roja G & Rao P S, Anticancer compounds from tissue cultures of medicinal plants (Reviews), J Herbs, Spices & Med Plants, 7 (2000) 71.
5. Huang Paul L, Huang Philip L, Huang P, Huang H I & Huang S L, Developing drugs from traditional madicinal plants, Chem Industry, 8 (1992) 290.
6. Taraphdar A K, Roy M & Bhattacharya R K, Natural products as inducers of apoptosis: Implication for cancer therapy and prevention, Curr Sci, 80 (2001) 1387.
7. Sakagami H, Ikeda M, Unten S, Takeda K, Murayama J I, Hamada A, Kimura K, Komatsu N & Konno K, Antitumor activity of polysaccharide fractions from pine cone extract of Pinus parviflora Sieb. Et Zucc, Anticancer Res, 7 (1987) 1153.
8. Sharma N, Trikha P, Athar M & Raisuddin S, Inhibitory effect of Emblica officinalis on the in vivo clastogenicity of benzo[a]pyrene and cyclophosphamide in mice, Human Exp Toxicol, 19 (2000) 377.
9. Chaudhuri T, Sur P, Gomes A, Das S K & Ganguly D K, Effect of tea root extract (TRE) on solid tumors induced by 3-methylcholanthrene in mice, Phyto Res, 12 (1998) 62.
10. Kuttan R, Bhanumathy P, Nirmala K & George M C, Potential anticancer activity of turmeric (Curcuma longa), Cancer Lett, 29 (1985) 197.
11. Sur P & Ganguly D K, Tea plant root extract (TRE) as an antineoplastic agent, Planta Med, 60 (1994) 105.
12. Azuine M A, Amonkar A J & Bhide S V, Chemopreventive efficacy of betel leaf extract and its constituents on 7, 12-dimethylbenz(a)anthracene induced carcinogenesis and their effect on drug detoxification system in mouse skin, Indian J Exp Biol, 29 (1991) 346.
13. Sllchenmyer W J & Von Hoff D D, Taxol: A new and effective anti-cancer drug (Review), Anti-Cancer Drugs, 2 (1991) 519.
14. Syiem D, Kharbuli B, Das B, Nongkhlaw D G, Thamar I, Marngar D, Syngai G, Kayang H, Myrboh B, Yobin Y S H & Buam D R M, Medicinal plants and herbal medicine: a case study in Meghalaya, in Biodiversity: North East India perspectives, edited by B Kharbuli, D Syiem & H Kayang (North Eastern Biodiversity Research Cell, North Eastern Hill University, Shillong, Meghalaya, India) 1999, 1.
15. Maikhuri R K & Gangwar A K, Ethnobotanical notes on the Khasi and Garo tribes of Meghalaya, northeast India, Econ Bot, 47 (1993) 345.
16. Lalramnghinglova J H, Ethnobotany of Mizoram - A preliminary survey, J Econ Taxon Bot, 12 (1996) 439.
17. Rynjah P S, Hand book on local health traditions in Meghalaya (Ri Khasi Offset Printers, Shillong), 1995, 1.
18. Arrick B A & Nathan C F, Glutathione metabolism as a determinant of therapeutic efficacy: A review, Cancer Res, 44 (1984) 4224.
19. Khynriam D & Prasad S B, Changes in endogenous tissue glutathione level in relation to murine ascites tumor growth and the anticancer activity of cisplatin, Brazilian J Med Biol Res, 36 (2003) 53.
20. Wang W & Ballatori N, Endogenous glutathione conjugates: Occurrence and biological functions, Pharmacological Rev, 50 (1998) 335.
21. Prasad S B & Giri A, Antitumor effect of cisplatin against murine ascites Dalton's lymphoma, Indian J Exp Biol, 32 (1994) 155.
22. Amadioha A C, Control of powdery mildew in pepper (Capsicum annum L.) by leaf extracts of papaya (Carica papaya L.), J Herbs, Spices Med Plants, 6 (1998) 41.
23. Alasbahi R H, Safiyeva S & Craker L E, Antimicrobial activity of some Yemeni medicinal plants, J Herbs, Spices Med Plants, 6 (1999) 75.
24. Lowry O H, Rosebrough N J, Farr A L & Randal R J, Protein measurement with the folin phenol reagent, J Biol Chem, 193 (1951) 265.
25. Sedlak J & Lindsay R H, Estimation of total, protein-bound and nonprotein sulfhydryl groups in tissue with Ellman's Reagent, Anal Biochem, 25 (1968) 192.
26. Nicol B M & Prasad S B, Sialic acid changes in Dalton's lymphoma-bearing mice after cyclophosphamide and cisplatin treatment, Brazilian J Med Biol Res, 35 (2002) 549.
27. Estrela J M, Sternandez R, Terradez P, Asensi M, Puertes I R & Vina J, Regulation of glutathione metabolism in Ehrlich ascites tumour cells, Biochem J, 286 (1992) 257.
28. Terradez P, Asensi M, Lasso De La Vega M C, Puertes I R, Vina J & Estrela J M, Depletion of tumour glutathione in vivo by buthionine sulphoximine: Modulation by the rate of cellular proliferation and inhibition of cancer growth, Biochem J, 292 (1993) 477.
29. Tanaka M, Obata T & Sasaki T, Evaluation of antitumour effects of docetaxel (Taxotere) on human gastric cancers in vitro and in vivo, European J Cancer, 32 (1996) 226.
30. st January 2004, Mumbai, 39
31. Meister A, The fall and rise of cellular glutathione levels: enzyme based approaches, Curr Top Cell Regul, 26 (1985) 383.
32. Arrick B A & Nathan C F, Glutathione metabolism as a determinant of therapeutic efficacy: A review, Cancer Res. 44 (1984) 4224.
33. Estrela J M, Hernandez R, Terradez P, Asensi M, Puertes I R & Vina J, Regulation of glutathione metabolism in Ehrlich ascites tumour cells, Biochem J, 286 (1992) 257.
34. Russo A, DeGraff W, Friedman N & Mitchell J B, Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapeutic drugs, Cancer Res, 46 (1986) 2845.
35. Navarro J, Obrador E, Carretero J, Petschen I, Avino J, Perez P & Estrela JM, Changes in glutathione status and the antioxidant system in blood and in cancer cells associate with tumour growth in vivo, Free Rad Biol Med, 26 (1999) 410.
36. Kane D J, Sarafian T A, Anton R, Hahn H, Gralla E B, Valentine J S, Ord T & Bredesen D E, Bcl-2 inhibition of neuronal death: Decreased generation of reactive oxygen species, Science, 262 (1993) 1274.
37. Khynriam D & Prasad S B, Cisplatin-induced genotoxic effects and endogenous glutathione levels in mice bearing ascites Dalton's lymphoma, Mutation Res, 526 (2003) 9.
38. Prasad S B, Giri A, Khynriam D, Kharbangar A, Nicol B M & Lotha C, Cisplatin-mediated enzymatic changes in mice bearing ascites Dalton's lymphoma, Midical Sci Res, 27 (1999) 723.